Showing results (1-10 of 500) with videos related to
Sort By:
Pageof 50
Giornale Italiano Di Cardiologia (2006)|May 17, 2022
[New evidence on coffee consumption, hypertension and cardiovascular diseases]Claudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
'Use of lipid-lowering therapy: the guidelines, the drugs or the patient?'Claudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|November 26, 2020
The new type 2 diabetes mellitus therapy: comparison between the two classes of drugs GLPR (glucagon-like peptide receptor) agonists and SGLT2 (sodium-glucose cotransporter 2) inhibitorsClaudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Pharmacological therapy in the obese patient: is it only a matter of fat loss?Claudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|April 24, 2023
Clinical results and mechanism of action of icosapent ethylClaudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|April 18, 2025
In these cases, I treat hypertension with renal ablationClaudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|June 13, 2024
There are those who would like zero LDL cholesterolClaudio Borghi, Alessio BragagniEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|October 15, 2021
Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetesAlessio Bragagni, Federica Piani, Claudio BorghiExpert Opinion on Drug Safety|October 13, 2020
Safety implications of combining ACE inhibitors with thiazides for the treatment of hypertensive patientsClaudio Borghi, Mario Soldati, Alessio Bragagni, et al.Pageof 50